Some observations on serum concentrations of digitoxin and digoxin. 1979

M Takahashi, and T Sada, and Y Taneichi, and F Okabe, and Y Ito, and A Morishima

Serum concentrations of digitoxin and digoxin were measured in 145 cases with various heart diseases receiving maintenance doses of digitalis. Digitalis toxicity was seen in only 2 cases (1.4%). Day-to-day variation of serum concentration while taking the same daily dose was small in digitoxin therapy (13.8%), but a considerable variation was seen in digoxin therapy (24.4%). Serum concentrations of both digitoxin and digoxin were measured in the patients receiving digitoxin, and there was a positive correlation between the two (r = 0.66, p less than 0.001). This fact suggested that the effect of digitoxin was the sum of the effects of digitoxin and its metabolite, digoxin. In the patients taking digoxin, digitoxin was not detected in the serum. Serum digitoxin level had a significantly positive correlation to serum albumin level, presumably because digitoxin was retained in serum in the bound form to albumin. Minimal effective level, 10 ng/ml, was however obtained with higher daily dose of digitoxin in patients with lower serum albumin.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D004074 Digitoxin A cardiac glycoside sometimes used in place of DIGOXIN. It has a longer half-life than digoxin; toxic effects, which are similar to those of digoxin, are longer lasting. (From Martindale, The Extra Pharmacopoeia, 30th ed, p665) Coramedan,Digimed,Digimerck,Digitaline Nativelle,Digitoxin AWD,Digitoxin Bürger,Digitoxin Didier,Digitoxin-Philo,Digophton,AWD, Digitoxin,Bürger, Digitoxin,Didier, Digitoxin,Digitoxin Philo,Nativelle, Digitaline
D004077 Digoxin A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666) Digacin,Digitek,Digoregen,Digoxina Boehringer,Digoxine Nativelle,Dilanacin,Hemigoxine Nativelle,Lanacordin,Lanicor,Lanoxicaps,Lanoxin,Lanoxin-PG,Lenoxin,Mapluxin,Boehringer, Digoxina,Lanoxin PG,Nativelle, Digoxine,Nativelle, Hemigoxine
D005260 Female Females
D006331 Heart Diseases Pathological conditions involving the HEART including its structural and functional abnormalities. Cardiac Disorders,Heart Disorders,Cardiac Diseases,Cardiac Disease,Cardiac Disorder,Heart Disease,Heart Disorder
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

M Takahashi, and T Sada, and Y Taneichi, and F Okabe, and Y Ito, and A Morishima
March 1975, Kokyu to junkan. Respiration & circulation,
M Takahashi, and T Sada, and Y Taneichi, and F Okabe, and Y Ito, and A Morishima
January 1996, European journal of clinical pharmacology,
M Takahashi, and T Sada, and Y Taneichi, and F Okabe, and Y Ito, and A Morishima
July 1974, Journal of the Tennessee Medical Association,
M Takahashi, and T Sada, and Y Taneichi, and F Okabe, and Y Ito, and A Morishima
July 1972, Archives of internal medicine,
M Takahashi, and T Sada, and Y Taneichi, and F Okabe, and Y Ito, and A Morishima
April 2001, American journal of clinical pathology,
M Takahashi, and T Sada, and Y Taneichi, and F Okabe, and Y Ito, and A Morishima
December 1974, The Journal of pharmacy and pharmacology,
M Takahashi, and T Sada, and Y Taneichi, and F Okabe, and Y Ito, and A Morishima
September 1983, Clinical pharmacology and therapeutics,
M Takahashi, and T Sada, and Y Taneichi, and F Okabe, and Y Ito, and A Morishima
March 1970, Journal of pharmaceutical sciences,
M Takahashi, and T Sada, and Y Taneichi, and F Okabe, and Y Ito, and A Morishima
January 1977, Arzneimittel-Forschung,
M Takahashi, and T Sada, and Y Taneichi, and F Okabe, and Y Ito, and A Morishima
August 1976, British journal of clinical pharmacology,
Copied contents to your clipboard!